This list is an analysis based on recent market events. It's not an investment recommendation.
SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two operating reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.
Show more...
FAQ
What is SciSparc stock price today?▼
The current price of SPRCY is $4.00 USD — it has decreased by -19.03% in the past 24 hours. Watch SciSparc stock price performance more closely on the chart.
What is SciSparc stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on PINX exchange SciSparc stocks are traded under the ticker SPRCY.
What is SciSparc market cap?▼
Today SciSparc has the market capitalization of 8.13M
What were SciSparc earnings last quarter?▼
SPRCY earnings for the last quarter are -3.52 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
How many employees does SciSparc have?▼
As of September 04, 2026, the company has 3 employees.
In which sector is SciSparc located?▼
SciSparc operates in the Health & Wellness sector.
When did SciSparc complete a stock split?▼
SciSparc has not had any recent stock splits.
Where is SciSparc headquartered?▼
SciSparc is headquartered in Tel Aviv, Israel.